227 related articles for article (PubMed ID: 29220296)
1. Carcinosarcomas and Related Cancers: Tumors Caught in the Act of Epithelial-Mesenchymal Transition.
Pang A; Carbini M; Moreira AL; Maki RG
J Clin Oncol; 2018 Jan; 36(2):210-216. PubMed ID: 29220296
[TBL] [Abstract][Full Text] [Related]
2. Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics.
Kernochan LE; Garcia RL
J Natl Compr Canc Netw; 2009 May; 7(5):550-6; quiz 557. PubMed ID: 19460280
[TBL] [Abstract][Full Text] [Related]
3. PD-L1 Expression in Carcinosarcomas of the Gynecologic Tract: A Potentially Actionable Biomarker.
Pinto A; Mackrides N; Nadji M
Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):393-397. PubMed ID: 27801734
[TBL] [Abstract][Full Text] [Related]
4. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
Costa MJ; Guinee D
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
[TBL] [Abstract][Full Text] [Related]
5. Uterine Carcinosarcomas - Diagnosis and Management.
Denschlag D; Ulrich UA
Oncol Res Treat; 2018; 41(11):675-679. PubMed ID: 30317231
[TBL] [Abstract][Full Text] [Related]
6. Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics.
Chen X; Arend R; Hamele-Bena D; Tergas AI; Hawver M; Tong GX; Wright TC; Wright JD
Int J Gynecol Pathol; 2017 Sep; 36(5):412-419. PubMed ID: 28700424
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-mesenchymal transition in carcinomas of the female genital tract.
Stewart CJ; McCluggage WG
Histopathology; 2013 Jan; 62(1):31-43. PubMed ID: 23240668
[TBL] [Abstract][Full Text] [Related]
8. Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component.
de Jong RA; Nijman HW; Wijbrandi TF; Reyners AK; Boezen HM; Hollema H
Mod Pathol; 2011 Oct; 24(10):1368-79. PubMed ID: 21572397
[TBL] [Abstract][Full Text] [Related]
9. Tissue-specific signatures of activating PIK3CA and RAS mutations in carcinosarcomas of gynecologic origin.
Growdon WB; Roussel BN; Scialabba VL; Foster R; Dias-Santagata D; Iafrate AJ; Ellisen LW; Tambouret RH; Rueda BR; Borger DR
Gynecol Oncol; 2011 Apr; 121(1):212-7. PubMed ID: 21168197
[TBL] [Abstract][Full Text] [Related]
10. Interobserver Reproducibility Among Gynecologic Pathologists in Diagnosing Heterologous Osteosarcomatous Component in Gynecologic Tract Carcinosarcomas.
Sangoi AR; Kshirsagar M; Roma AA; Horvai AE; Chivukula M; Ellenson LH; Fadare O; Folkins AK; Garg K; Hanley K; Longacre TA; Haas J; McCluggage WG; McKenney JK; Nucci MR; Oliva E; Park KJ; Parkash V; Quick CM; Rabban JT; Rutgers JKL; Soslow R; Vang R; Yemelyanova A; Zaloudek C; Beck AH
Int J Gynecol Pathol; 2017 Jul; 36(4):386-392. PubMed ID: 28221217
[TBL] [Abstract][Full Text] [Related]
11. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas.
McCluggage WG
Int J Gynecol Cancer; 2002; 12(6):687-90. PubMed ID: 12445244
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous adnexal carcinosarcoma: Immunohistochemical and molecular evidence of epithelial mesenchymal transition.
Kwon D; Ronen S; Giubellino A; Keiser E; Aung PP; Nagarajan P; Tetzlaff MT; Ivan D; Curry JL; Prieto VG; Torres-Cabala CA
J Cutan Pathol; 2021 Apr; 48(4):526-534. PubMed ID: 32564423
[TBL] [Abstract][Full Text] [Related]
13. Pathology of mixed Müllerian tumours.
D'Angelo E; Prat J
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):705-18. PubMed ID: 21742560
[TBL] [Abstract][Full Text] [Related]
14. Carcinosarcomas: tumors in transition?
Somarelli JA; Boss MK; Epstein JI; Armstrong AJ; Garcia-Blanco MA
Histol Histopathol; 2015 Jun; 30(6):673-87. PubMed ID: 25587806
[TBL] [Abstract][Full Text] [Related]
15. Biphasic malignant tumours of the abdominal cavity.
Almond LM; Warfield AT; Desai A; Gourevitch D; Ford SJ
Int J Clin Oncol; 2017 Aug; 22(4):635-640. PubMed ID: 28656498
[TBL] [Abstract][Full Text] [Related]
16. Carcinosarcoma of the ovary a review.
Cantrell LA; Van Le L
Obstet Gynecol Surv; 2009 Oct; 64(10):673-80; quiz 697. PubMed ID: 19772676
[TBL] [Abstract][Full Text] [Related]
17. Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas.
Franceschi T; Durieux E; Morel AP; de Saint Hilaire P; Ray-Coquard I; Puisieux A; Devouassoux-Shisheboran M
Virchows Arch; 2019 Jul; 475(1):85-94. PubMed ID: 30739164
[TBL] [Abstract][Full Text] [Related]
18. p53 gene mutation in female genital tract carcinosarcomas (malignant mixed müllerian tumors): a clinicopathologic study of 74 cases.
Costa MJ; Vogelsan J; Young LJ
Mod Pathol; 1994 Aug; 7(6):619-27. PubMed ID: 7991520
[TBL] [Abstract][Full Text] [Related]
19. Extravascular migratory metastasis in gynaecological carcinosarcoma.
Dyke JM; Crook ML; Platten M; Stewart CJ
Histopathology; 2014 Sep; 65(3):363-70. PubMed ID: 24734932
[TBL] [Abstract][Full Text] [Related]
20. Analysis by comparative genomic hybridization of epithelial and spindle cell components in sarcomatoid carcinoma and carcinosarcoma: histogenetic aspects.
Torenbeek R; Hermsen MA; Meijer GA; Baak JP; Meijer CJ
J Pathol; 1999 Nov; 189(3):338-43. PubMed ID: 10547594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
